BZI-ROCE

Pulled from Benzinga Pro data, Nelnet (NYSE:NNI) posted Q1 earnings of $23.02 million, an increase from Q4 of 17.75%. Sales dropped to $331.67 million, a 1.5% decrease between quarters. In Q4, Nelnet earned $27.98 million, and total sales reached $336.72 million. Why Is ROCE Significant? Return on...

Pulled from Benzinga Pro data, PayPal Holdings (NASDAQ:PYPL) posted Q1 earnings of $795.00 million, an increase from Q4 of 13.68%. Sales dropped to $7.04 billion, a 4.65% decrease between quarters. In Q4, PayPal Holdings earned $921.00 million, and total sales reached $7.38 billion. What Is ROCE?...

According to Benzinga Pro, during Q1, DaVita (NYSE:DVA) earned $170.67 million, a 34.79% increase from the preceding quarter. DaVita's sales decreased to $2.87 billion, a 1.51% change since Q4. In Q4, DaVita earned $126.61 million, whereas sales reached $2.92 billion. What Is ROIC? Return on...

According to Benzinga Pro data Palantir Technologies (NYSE:PLTR) posted a 42.81% decrease in earnings from Q4. Sales, however, increased by 3.26% over the previous quarter to $525.19 million. Despite the increase in sales this quarter, the decrease in earnings may suggest Palantir Technologies is...

According to Benzinga Pro, during Q1, Alpha Metallurgical (NYSE:AMR) earned $270.77 million, a 22.7% increase from the preceding quarter. Alpha Metallurgical also posted a total of $911.24 million in sales, a 10.66% increase since Q4. Alpha Metallurgical earned $220.68 million, and sales totaled $...

According to Benzinga Pro data, during Q1, Axsome Therapeutics (NASDAQ:AXSM) posted sales of $94.58 million. Earnings were up 81.68%, but Axsome Therapeutics still reported an overall loss of $11.22 million. Axsome Therapeutics collected $24.37 million in revenue during Q4, but reported earnings...

Akebia Therapeutics (NASDAQ:AKBA) brought in sales totaling $40.13 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 247.15%, resulting in a loss of $26.22 million. Akebia Therapeutics collected $55.18 million in revenue during Q4, but reported earnings...

Benzinga Pro data, Tyson Foods (NYSE:TSN) reported Q2 sales of $13.13 billion. Earnings fell to a loss of $91.00 million, resulting in a 128.44% decrease from last quarter. In Q1, Tyson Foods earned $320.00 million, and total sales reached $13.26 billion. What Is Return On Capital Employed?...

Pulled from Benzinga Pro data, Energizer Hldgs (NYSE:ENR) posted Q2 earnings of $40.00 million, an increase from Q1 of 18.37%. Sales dropped to $684.10 million, a 10.59% decrease between quarters. In Q1, Energizer Hldgs earned $49.00 million, and total sales reached $765.10 million. What Is Return...

Pulled from Benzinga Pro data, DISH Network (NASDAQ:DISH) posted Q1 earnings of $243.24 million, an increase from Q4 of 74.52%. Sales dropped to $3.96 billion, a 2.13% decrease between quarters. DISH Network earned $954.47 million, and sales totaled $4.04 billion in Q4. What Is Return On Invested...

Pulled from Benzinga Pro data, Hyatt Hotels (NYSE:H) showed a loss in earnings since Q4, totaling $58.00 million. Sales, on the other hand, increased by 5.79% to $1.68 billion during Q1. In Q4, Hyatt Hotels earned $294.00 million and total sales reached $1.59 billion. Why Is ROIC Significant?...

Pulled from Benzinga Pro data, Antero Resources (NYSE:AR) posted Q1 earnings of $261.20 million, an increase from Q4 of 67.11%. Sales dropped to $1.41 billion, a 32.42% decrease between quarters. Antero Resources earned $794.13 million, and sales totaled $2.08 billion in Q4. What Is ROIC? Earnings...

Benzinga Pro data, MISTRAS Group (NYSE:MG) reported Q1 sales of $168.02 million. Earnings fell to a loss of $4.98 million, resulting in a 273.63% decrease from last quarter. MISTRAS Group earned $2.87 million, and sales totaled $168.22 million in Q4. What Is ROIC? Return on Invested Capital is a...

Benzinga Pro data, Ovid Therapeutics (NASDAQ:OVID) reported Q1 sales of $66 thousand. Earnings fell to a loss of $13.36 million, resulting in a 16.09% decrease from last quarter. Ovid Therapeutics collected $46 thousand in revenue during Q4, but reported earnings showed a $11.50 million loss....

According to Benzinga Pro, during Q4, Advanced Drainage Systems (NYSE:WMS) earned $86.31 million, a 3.76% increase from the preceding quarter. Advanced Drainage Systems's sales decreased to $617.56 million, a 5.74% change since Q3. In Q3, Advanced Drainage Systems earned $83.18 million, whereas...